完善个人信息
取消
| | CAS号 | |英文名称 | | 中文名称 | | 分子式 | | 分子量 |
|---|---|---|---|---|
| 459856-18-9 | Pexacerfont | 8-(6-甲氧基-2-甲基-3-吡啶基)-2,7-二甲基-N-[(1R)-1-甲基丙基]吡唑并[1,5-A]-1,3,5-三嗪-4-胺 | C18H24N6O | 340.42 |
| 2230198-02-2 | PF-06882961 | PF-06882961 | C31H30FN5O4 | 555.6 |
| 1306760-87-1 | Ozanimod | 奥扎莫德 | C23H24N4O3 | 404.46 |
| 1257213-50-5 | BMS-986020 | CS-2492 | C29H26N2O5 | 482.53 |
| 954126-98-8 | Danirixin | GSK1325756 | C19H21ClFN3O4S | 441.9 |
| 90098-04-7 | Rebamipide | 瑞巴派特 | C19H15ClN2O4 | 370.79 |
| 882366-16-7 | m-tolyl 5-chloro-2-(ethylsulfonyl)pyrimidine-4-carboxylate | SBI-115; SBI 115; SBI115 | C14H13ClN2O4S | 340.78 |
| 878141-96-9 | S1RA | S1RA | C20H23N3O2 | 337.42 |
| 870070-55-6 | 4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-2-benzothiazolyl]-4-methyl-1-piperidinecarboxamide | 4-羟基-N-[4-甲氧基-7-(4-吗啉基)-2-苯并噻唑基]-4-甲基-1-哌啶甲酰胺 | C19H26N4O4S | 406.5 |
| 863031-21-4 | Azilsartan Medoxomil | 阿奇沙坦酯 | C30H24N4O8 | 568.53 |
